Cargando…
The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as AR...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442440/ https://www.ncbi.nlm.nih.gov/pubmed/31011583 http://dx.doi.org/10.1155/2019/8989241 |
_version_ | 1783407711310839808 |
---|---|
author | Zhang, Yanqiu Han, A'meng Fu, Zhanzhao Xu, Shufeng Zhang, Zijian |
author_facet | Zhang, Yanqiu Han, A'meng Fu, Zhanzhao Xu, Shufeng Zhang, Zijian |
author_sort | Zhang, Yanqiu |
collection | PubMed |
description | Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), helical tomotherapy (HT), and so forth are also developing quickly. In this paper, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. Ten patients with stage IIIA-N2 completely resected NSCLC, whom were treated by PORT in the radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. For each patient, the CRT plan, IMRT plan, ARC plan, CRT+IMRT plan, and CRT+ARC plan were designed separately on the same set of CT images. The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OAR (organs at risk), and the normal tissue (defined as body subtracted to PTV (planning target volume), B-P). No plan had absolute dosimetry advantages than any other plans. In clinical practice, the plans could be chosen according to their dosimetry characteristics. |
format | Online Article Text |
id | pubmed-6442440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-64424402019-04-22 The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients Zhang, Yanqiu Han, A'meng Fu, Zhanzhao Xu, Shufeng Zhang, Zijian Biomed Res Int Research Article Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), helical tomotherapy (HT), and so forth are also developing quickly. In this paper, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. Ten patients with stage IIIA-N2 completely resected NSCLC, whom were treated by PORT in the radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. For each patient, the CRT plan, IMRT plan, ARC plan, CRT+IMRT plan, and CRT+ARC plan were designed separately on the same set of CT images. The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OAR (organs at risk), and the normal tissue (defined as body subtracted to PTV (planning target volume), B-P). No plan had absolute dosimetry advantages than any other plans. In clinical practice, the plans could be chosen according to their dosimetry characteristics. Hindawi 2019-03-18 /pmc/articles/PMC6442440/ /pubmed/31011583 http://dx.doi.org/10.1155/2019/8989241 Text en Copyright © 2019 Yanqiu Zhang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zhang, Yanqiu Han, A'meng Fu, Zhanzhao Xu, Shufeng Zhang, Zijian The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients |
title | The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients |
title_full | The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients |
title_fullStr | The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients |
title_full_unstemmed | The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients |
title_short | The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients |
title_sort | dosimetric comparisons of crt, imrt, arc, crt+imrt, and crt+arc of postoperative radiotherapy in iiia-n2 stage non-small-cell lung cancer patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442440/ https://www.ncbi.nlm.nih.gov/pubmed/31011583 http://dx.doi.org/10.1155/2019/8989241 |
work_keys_str_mv | AT zhangyanqiu thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients AT hanameng thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients AT fuzhanzhao thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients AT xushufeng thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients AT zhangzijian thedosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients AT zhangyanqiu dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients AT hanameng dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients AT fuzhanzhao dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients AT xushufeng dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients AT zhangzijian dosimetriccomparisonsofcrtimrtarccrtimrtandcrtarcofpostoperativeradiotherapyiniiian2stagenonsmallcelllungcancerpatients |